News tagged ‘OvarianCancer’ clear
- One of the shortcomings of a therapy that uses millions of
identical antibodies to boost the immune system's attack on cancer cells
is that many patients whose tumors recede in response to the treatment
also experience serious inflammatory problems, such as severe diarrhea
and rashes. In a new study, a team led by Dana-Farber Cancer Institute
researchers shows that giving periodic infusions of such "monoclonal"
antibodies to patients who have received a widely used cancer vaccine
unleashes a strong immune response to tumors, with less-harsh side
effects.
Tags: Melanoma, OvarianCancer, TargetedTherapy
A new study that proposes a three-in-one test for gynecologic cancers underscores the promise of molecular screening for early detection of endometrial and ovarian cancers, but also suggests that such tests are not yet ready for clinical use. Andrea Myers, MD, PhD, a co-author of the commentary on the study, says the test is an important step in that direction.
Tags: CervicalCancer, OvarianCancer, Prevention, GynecologicCancers
Dana-Farber/Brigham and Women's Cancer Center and the Massachusetts Ovarian Cancer Awareness Coalition want women to get the facts and recognize the signs of the disease.
Tags: OvarianCancer, GynecologicCancers
Research led by Dana-Farber Cancer Institute scientists may soon enable doctors to determine which patients with the most common form of ovarian cancer – high-grade serous ovarian cancer (HGSOC) – are most likely to benefit from a certain class of drugs.
Tags: OvarianCancer, GynecologicCancers
The discovery of a subtype of ovarian cancer that could account for up to one-third of all serous ovarian cancers may lead to clinical trials using anti-angiogenic drugs that are already being tested in other cancers.
Tags: OvarianCancer, GynecologicCancers
As part of Project Achilles, aimed at finding the "Achilles heel" of cancer, researchers from Dana-Farber Cancer Institute, Harvard and the Broad Institute of MIT examined cells from over 100 tumors, including 25 ovarian cancer tumors, finding promising new targets for genetic research.
Tags: BasicResearch, OvarianCancer, GynecologicCancers
- On Sept. 6 at Boston City Hall Plaza, Dana-Farber/Brigham and Women's Cancer Center, along with a coalition of six organizations, launched a month-long campaign to promote ovarian cancer awareness. The group, known as OvarianCancerAwareness.org, is dedicated to educating the public about the subtle symptoms of ovarian cancer to promote early detection.
Tags: OvarianCancer
A new Dana-Farber Cancer Institute study suggests there is a direct connection between high-grade serous ovarian cancer (HGSOC) and fallopian tubes. The finding could aid in the development of better treatments for the cancer.
Tags: OvarianCancer, GynecologicCancers